Boxer Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,500,000
| Closed | -$2.85M | – | 71 |
|
|
2024
Q2 | $2.85M | Hold |
1,500,000
| – | – | 0.15% | 49 |
|
|
2024
Q1 | $4.26M | Buy |
+1,500,000
| New | +$4.26M | 0.21% | 48 |
|
|
2023
Q4 | – | Sell |
-2,084,000
| Closed | -$38.2M | – | 54 |
|
|
2023
Q3 | $38.2M | Hold |
2,084,000
| – | – | 2.03% | 18 |
|
|
2023
Q2 | $45M | Hold |
2,084,000
| – | – | 2.08% | 17 |
|
|
2023
Q1 | $61.1M | Hold |
2,084,000
| – | – | 3% | 11 |
|
|
2022
Q4 | $77M | Hold |
2,084,000
| – | – | 4.06% | 8 |
|
|
2022
Q3 | $58.7M | Sell |
2,084,000
-116,000
| -5% | -$3.27M | 3.3% | 8 |
|
|
2022
Q2 | $42.4M | Hold |
2,200,000
| – | – | 2.68% | 14 |
|
|
2022
Q1 | $28.3M | Buy |
+2,200,000
| New | +$28.3M | 1.45% | 22 |
|